Patents Assigned to Hafslund Nycomed A/S
  • Patent number: 4956344
    Abstract: A method for the treatment of hyperproliferative benign or malignant lesions in the large intestinal epithelium is provided.The method comprises administering the tripeptide L-pyroglutamyl-L-histidyl-glycine of the formula: ##STR1## in which the pyroglutamyl and histidyl moieties are of the L-configuration.
    Type: Grant
    Filed: February 1, 1989
    Date of Patent: September 11, 1990
    Assignee: Hafslund Nycomed A/S
    Inventors: Tellef Fossli, Karl L. Reichelt, Oyvind Skraastad, Paul D. Edminson